Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?

Ferro, Antonella; Generali, Daniele; Caffo, Orazio; Caldara, Alessia; De Lisi, Delia; Dipasquale, Mariachiara; Lorenzi, Martina; Monteverdi, Sara; Fedele, Palma; Ciribilli, Yari.

Afiliación

Ferro A; Medical Oncology, Breast Unit Santa Chiara Hospital, APSS Trento, Largo Medaglie D'Oro, Trento, Italy. Electronic address: antonella.ferro@apss.tn.it.
Generali D; UO Patologia Mammaria, Cremona Hospital, ASST Cremona, Italy; Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy.
Caffo O; Medical Oncology Unit, Santa Chiara Hospital, APSS Trento, Italy.
Caldara A; Medical Oncology, Breast Unit Santa Chiara Hospital, APSS Trento, Largo Medaglie D'Oro, Trento, Italy.
De Lisi D; Medical Oncology, Breast Unit Santa Chiara Hospital, APSS Trento, Largo Medaglie D'Oro, Trento, Italy.
Dipasquale M; Medical Oncology, Breast Unit Santa Chiara Hospital, APSS Trento, Largo Medaglie D'Oro, Trento, Italy.
Lorenzi M; Medical Oncology, Breast Unit Santa Chiara Hospital, APSS Trento, Largo Medaglie D'Oro, Trento, Italy.
Monteverdi S; Medical Oncology, Breast Unit Santa Chiara Hospital, APSS Trento, Largo Medaglie D'Oro, Trento, Italy.
Fedele P; Oncology Unit, Dario Camberlingo Hospital, ASL Brindisi, Francavilla Fontana, Italy.
Ciribilli Y; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Povo, Italy. Electronic address: yari.ciribilli@unitn.it.